Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Hepatitis C among noninjecting drug users: A report
Autore:
Tortu, S; Neaigus, A; McMahon, J; Hagen, D;
Indirizzi:
Tulane Univ, Sch Publ Hlth & Trop Med, Dept Community Hlth Sci, New Orleans, LA 70112 USA Tulane Univ New Orleans LA USA 70112 Hlth Sci, New Orleans, LA 70112 USA Natl Dev & Res Inst Inc, World Trade Ctr 2, New York, NY 10048 USA Natl Dev & Res Inst Inc New York NY USA 10048 r 2, New York, NY 10048 USA
Titolo Testata:
SUBSTANCE USE & MISUSE
fascicolo: 4, volume: 36, anno: 2001,
pagine: 523 - 534
SICI:
1082-6084(2001)36:4<523:HCANDU>2.0.ZU;2-R
Fonte:
ISI
Lingua:
ENG
Soggetto:
VIRUS-INFECTION; LIVER-DISEASE; SEXUAL TRANSMISSION; ALCOHOL; RISK; PROGRESSION; PREVALENCE; ABSENCE; SEMEN; MEN;
Keywords:
hepatitis C; noninjecting drug use; heroin use; crack use; cocaine use;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Tortu, S Tulane Univ, Sch Publ Hlth & Trop Med, Dept Community Hlth Sci, 1440 CanalSt,Suite 2301, New Orleans, LA 70112 USA Tulane Univ 1440 Canal St,Suite 2301 New Orleans LA USA 70112 USA
Citazione:
S. Tortu et al., "Hepatitis C among noninjecting drug users: A report", SUBST USE M, 36(4), 2001, pp. 523-534

Abstract

Objectives: This report documents the prevalence of hepatitis C virus (HCV) infection among self-reported noninjecting drug users recruited from two New York City neighborhoods. Methods: Participants were recruited in separate studies from East Harlem and the Lower East Side of Manhattan and were administered structured questionnaires and tested for HCV. Results: HCV prevalence rates among those reporting no history of injecting drugs ranged from 5% to 29%, according to age, gender, and study location. Conclusions: Ourresults suggest that more research is needed to elucidate potential noninjecting routes of HCV transmission among drug users, Moreover, policies thatrely predominantly on injector status as the only drug-related risk factorfor HCV screening need to be reassessed in light of these findings.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/03/20 alle ore 23:07:43